ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Economics"

  • 2018 American Transplant Congress

    Cost Effectiveness of Lifelong Medicare Immunosuppressant Drug Coverage for Kidney Transplant Recipients in the Current Era

    M. Kadatz,1 J. Gill,2 J. Gill,2 K. Scott.3

    1Clinician Investigator Program, University of British Columbia, Vancouver, BC, Canada; 2Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; 3Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.

    While there is no Medicare time limit for dialysis patients, kidney transplant recipients lose their Medicare coverage 36 months after they receive their transplant. The…
  • 2018 American Transplant Congress

    Treatment Patterns and Burden among Chronic Graft versus Host Disease Patients on Second-Line Systemic Treatments Including Extracorporeal Photopheresis

    X. Huang,2 N. Joshi,1 L. Luo,1 G. Mitri,3 B. Lovelace,2 A. Pham,3 X. Gao.1

    1Pharmerit International, Bethesda, MD; 2Mallinckrodt Pharmaceuticals, Bedminster, NJ; 3Formerly of Mallinckrodt Pharmaceuticals, Bedminster, NJ.

    Extracorporeal Photopheresis (ECP) is a cell-based immunomodulatory therapeutic procedure reimbursable by the Centers for Medicare and Medicaid Services for patients with chronic Graft versus Host…
  • 2018 American Transplant Congress

    The Living Donor Lost Wages Trial: Study Rationale, Protocol, and Update

    J. Rodrigue,1 M. Pavlakis,1 A. Evenson,1 A. Fleishman,1 M. Carroll,1 D. Mandelbrot,2 P. Baliga,3 D. Howard,4 J. Schold.5

    1Beth Israel Deaconess Medical Center, Boston, MA; 2University of Wisconsin, Madison, WI; 3Medical University of South Carolina, Charleston, SC; 4Emory University, Atlanta, GA; 5Cleveland Clinic, Cleveland, OH.

    Living donor kidney transplantation (LDKT) is the optimal treatment for adults with renal failure. However, living kidney donation has declined in the past decade, particularly…
  • 2018 American Transplant Congress

    Evaluation of Financial Well-Being of Living Kidney Donor Candidates

    S. Singh,1,2 G. Bannerman,2 A. Yantsis,2 M. Liu,2 F. Gumabay,2 O. Famure.2

    1Division of Nephrology, Department of Medicine, University of Toronto, Toronto, ON, Canada; 2Division of Nephrology and the Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

    Despite the known benefits of living donor kidney transplantation, the rate of living kidney donation in Canada has not increased. Potential reasons include the lack…
  • 2018 American Transplant Congress

    Cost Impacts of Alternative Kidney Transplant Immunosuppression: A National Cohort Study

    K. Lentine,1 D. Axelrod,2 V. Dharnidharka,3 H. Xiao,1 D. Brennan,4 D. Segev,4 H. Randall,1 R. Ouseph,1 A. Naik,5 N. Lam,6 T. Alhamad,3 B. Kasiske,7 G. Hess,8 M. Schnitzler.1

    1Saint Louis Univ, St. Louis; 2Lahey Clinic, Burlington; 3Washington Univ, St. Louis; 4Johns Hopkins, Baltimore; 5Univ Michigan, Ann Arbor; 6Univ Alberta, Edmonton, Canada; 7Hennepin County, Minneapolis; 8Symphony Health, Conshohocken.

    Economic outcomes are increasingly considered along with clinical efficacy to guide choice of alternative therapies. We examined the cost impact of kidney transplant (KTx) induction…
  • 2018 American Transplant Congress

    Occupational and Financial Outcomes of Directed and Non-Directed Living Liver Donors

    J. Steel, M. Dulovich, K. Kingsley, S. Ganesh, O. Ola, A. Lai, S. Shen, N. Zharichenko, S. Nawaz, A. Tevar, C. Hughes, A. Humar.

    Surgery, University of Pittsburgh, Pittsburgh, PA.

    Background: Few transplant centers accept directed and non-directed living liver donors. The aims of this study were to compare the occupational and financial outcomes of…
  • 2018 American Transplant Congress

    The Cost Savings of Preemptive Kidney Transplantation

    P. Dean,1 H. Heien,2 K. Swanson,2 B. Borah,2 L. Sangaralingham,2 J. Naessens,2 M. Stegall.1

    1Division of Transplantation Surgery, Mayo Clinic, Rochester, MN; 2Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MD.

    Introduction: Preemptive kidney transplantation (PreKTx) is associated with improved patient survival and quality of life. The goal of this study was to compare the costs…
  • 2018 American Transplant Congress

    Living Liver Donors Face Substantial Out-of-Pocket Donation-Related Costs

    J. Ruck, A. Massie, J. Garonzik-Wang, S. Ottman, A. Cameron, B. Philosophe, D. Segev.

    Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD.

    While financial barriers to living kidney donation have been recognized, and the associated costs have been characterized limited data exist on the costs incurred by…
  • 2018 American Transplant Congress

    Hospitalization, Dialysis Center Type, and Disparities in ESRD Survival and Waitlist Access

    R. Lynch, R. Zhang, A. Adams, R. Patzer.

    Surgery, Emory University, Atlanta, GA.

    Background: Excess hospitalization has been shown to reduce kidney transplant waitlist survival and likelihood of transplant. We studied hospitalization as a predictor of waitlist access…
  • 2018 American Transplant Congress

    Financial Impact of Testing Standardization for Solid Organ Transplant Recipients

    S. Ugolini,2 L. Dranow,1 P. Sadler,2 M. Berry,2 J. Stehlik,1 S. Drakos,1 J. Nativi,1 E. Gilbert,1 S. McKeller,1 A. Koliopoulou,1 M. Yin,1 E. Davis,2 C. Selzman,1 O. Wever-Pinzon.1

    1Division of Cardiology, University of Utah Health, Salt Lake City, UT; 2Transplant Service Line, University of Utah Health, Salt Lake City, UT.

    Background: Infection and bone marrow suppression surveillance is common practice in transplant recipients. Ordering of inappropriate lab tests can lead to repetitive blood draws, higher…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 19
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences